Direkt zum Inhalt

Owner only: item control page
Borst, Andreas ; Haferkamp, Sebastian ; Grimm, Johannes ; Rösch, Manuel ; Zhu, Guannan ; Guo, Sen ; Li, Chunying ; Gao, Tianwen ; Meierjohann, Svenja ; Schrama, David ; Houben, Roland

BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines

Borst, Andreas, Haferkamp, Sebastian, Grimm, Johannes, Rösch, Manuel, Zhu, Guannan, Guo, Sen, Li, Chunying, Gao, Tianwen, Meierjohann, Svenja, Schrama, David and Houben, Roland (2017) BIK is involved in BRAF/MEK inhibitor induced apoptosis in melanoma cell lines. Cancer Letters 404, pp. 70-78.

Date of publication of this fulltext: 20 Mar 2019 13:14
Article



Involved Institutions


Details

Item typeArticle
Journal or Publication TitleCancer Letters
Publisher:ELSEVIER IRELAND LTD
Place of Publication:CLARE
Volume:404
Page Range:pp. 70-78
Date2017
InstitutionsMedicine > Lehrstuhl für Dermatologie und Venerologie
Identification Number
ValueType
10.1016/j.canlet.2017.07.005DOI
KeywordsBREAST-CANCER CELLS; HISTONE DEACETYLASE INHIBITORS; ENDOPLASMIC-RETICULUM BIK; POTENT ANTITUMOR-ACTIVITY; BCL-2 FAMILY-MEMBERS; PHASE-II TRIAL; BH3-ONLY PROTEIN; METASTATIC MELANOMA; MULTIPLE-MYELOMA; MEK INHIBITION; Melanoma; Vemurafenib; Trametinib; BIK/NBK; Apoptosis
Dewey Decimal Classification600 Technology > 610 Medical sciences Medicine
StatusPublished
RefereedYes, this version has been refereed
Created at the University of RegensburgYes
Item ID39768

Export bibliographical data

Owner only: item control page

nach oben